SF-6D schizophrenia Peasgood Depression/ Good EQ-5D To assess the construct validity 26 (26) (2012) Anxiety and responsiveness of EQ-5D SF-6D and SF-6D measures in depression and anxiety HUI 3 Hounsome Dementia Poor EQ-5D To review evidence relating the 21 (18) (2011) application of EQ-5D in HUI 3 dementia research and issues concerning its use Neoplasm Longworth Cancer Good EQ-5D To assess the reliability, validity 98 (98) (2014) and responsiveness of the SF-6D HUI 3 and SF-6D for measuring health related quality HUI 3 of life in cancer Pickard Cancer Poor EQ-5D To summarize evidence on the 34 (34) (2008) validity and reliability of EQ-5D in cancer Nervous system Kuspinar and Multiple EQ-5D To summarize the evidence from 15 (15) Mayo (2014) Sclerosis published literature on the SF-6D psychometric properties of a generic utility measures in HUI 3
SF-6D schizophrenia Peasgood (2012) Depression/ Anxiety Good EQ-5D SF-6D HUI 3 To assess the construct validity and responsiveness of EQ-5D and SF-6D measures in depression and anxiety 26 (26) Hounsome (2011) Dementia Poor EQ-5D HUI 3 To review evidence relating the application of EQ-5D in dementia research and issues concerning its use 21 (18) Neoplasm Longworth (2014) Cancer Good EQ-5D SF-6D HUI 3 To assess the reliability, validity and responsiveness of the HUI 3 and SF-6D for measuring health related quality of life in cancer 98 (98) Pickard (2008) Cancer Poor EQ-5D To summarize evidence on the validity and reliability of EQ-5D in cancer 34 (34) Nervous system Kuspinar and Mayo (2014) Multiple Sclerosis EQ-5D SF-6D HUI 3 To summarize the evidence from published literature on the psychometric properties of a generic utility measures in 15 (15)
PhD%20thesis%20FINAL_after%20VIVA_SUBMITED.docx